Sensei Biotherapeutics SNSE Q1 2026 Earnings Massive EPS Miss Overshadowed by Upbeat Sentiment Unicycive Therapeutics UNCY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development FCAP Q1 2026 Earnings EPS of 130 Highlights Cost Discipline Amid Modest Operating Environment Eagle Point Income Company Inc EIC Q4 2025 Earnings Slight EPS Miss but Stock Holds Steady Rexford Industrial Realty REXR Q1 2026 Earnings Strong EPS Beat Drives Surprise but Stock Slips OCCIN Q1 2026 Earnings Massive EPS Miss Casts Doubt on Portfolio Performance